New Considerations for a Totally Implantable Active Middle Ear Implant
| Autor: | Jacqueline Bibee, Jack A. Shohet |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Moderate to severe
Hearing aid medicine.medical_specialty Hearing loss Mini Review medicine.medical_treatment implants Audiology otology Otology medicine otorhinolaryngologic diseases RC346-429 Limited vision hearing loss business.industry Middle Ear Implant medicine.disease direct drive active middle ear implant speech perception gap medicine.anatomical_structure Neurology Middle ear Sensorineural hearing loss Neurology (clinical) Neurology. Diseases of the nervous system medicine.symptom business |
| Zdroj: | Frontiers in Neurology, Vol 12 (2021) Frontiers in Neurology |
| ISSN: | 1664-2295 |
| DOI: | 10.3389/fneur.2021.747887/full |
| Popis: | Totally implantable active middle ear implants (AMEI) provide full-time hearing amplification to those with moderate to severe sensorineural hearing loss. While technology in conventional hearing aids (CHA) has advanced greatly, limitations remain for people with active lifestyles, limited vision or dexterity, and hearing aid fit issues. Furthermore, direct-drive properties of AMEI are thought to provide those with inefficient middle ear transfer functions a distinct advantage in delivering prescribed sound to the cochlea, ultimately improving speech understanding with less distortion. AMEI safety, stability, and efficacy outcomes are well documented and fitting strategies continue to improve. Recent studies show how simple aided speech testing can help predict whether a patient struggling with CHA may instead benefit from an AMEI. Totally implantable AMEI continue to be a viable option for patients who cannot or will not utilize traditional hearing aids. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|